511509 — Vivo Bio Tech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Vivo Bio Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	10.3	11.7	17.1	13.7	13.9
Net Total Accounts Receivable
Net Total Receivables	147	120	136	192	360
Total Inventory
Total Other Current Assets
Total Current Assets	269	271	260	318	472
Net Property, Plant And Equipment	288	410	824	800	815
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	637	795	1,225	1,230	1,371
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	206	218	244	250	379
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	307	370	765	712	827
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	330	425	459	519	544
Total Liabilities & Shareholders' Equity	637	795	1,225	1,230	1,371
Total Common Shares Outstanding